Fluidization granulation method for exemestane tablets

By using fluidized bed and top spray technology, exemestane and soluble excipients are uniformly sprayed together, solving the problem of uneven dispersion of poorly soluble exemestane in traditional granulation and achieving high-quality formulation products.

CN118948784APending Publication Date: 2024-11-15ANHUI PIOM PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411048349.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-01
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Exemestane is a poorly soluble drug, and traditional granulation methods are insufficient to achieve adequate dispersion and uniform mixing of the raw materials, resulting in unstable product quality.

Method used

Fluidized bed granulation is used to uniformly spray the drug raw materials and soluble excipients in a fluidized state. Combined with the use of binders and excipients, uniform granules are prepared.

Benefits of technology

This achieved uniform dispersion and stable dissolution of exemestane tablets, improving product quality consistency and dissolution release stability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948784A_ABST
    Figure CN118948784A_ABST
Patent Text Reader

Abstract

The invention relates to a fluidization granulation method for exemestane tablets, raw materials are prepared according to the prescription dosage of the exemestane tablets, and the fluidization granulation method comprises the following steps: 1, adding hydroxypropyl methylcellulose into purified water, uniformly stirring, adding polysorbate, and uniformly stirring to obtain a hydroxypropyl methylcellulose solution; step 2, adding exemestane into the hydroxypropyl methylcellulose solution while stirring until exemestane is completely dispersed, and sieving to obtain a suspension for later use; 3, carrying out top spray granulation by using a fluidized bed, adding mannitol and microcrystalline cellulose into the fluidized bed, atomizing the suspension, and spraying the atomized suspension into a boiling hopper; and 4, granulating the material obtained in the step 3 and colloidal silicon dioxide by using an oscillating granulator. According to the preparation method, the raw materials are fully dispersed into the solution, and then the solution obtained after the raw materials are dispersed is uniformly sprayed on the specific soluble auxiliary material by utilizing a fluidization top spraying granulation process, so that the raw materials are uniformly distributed on the surface of the soluble auxiliary material, and a high-quality product which is uniform in particle, stable in dissolution and release and guaranteed in product quality is prepared.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of pharmaceuticals and relates to a fluidized granulation method for exemestane tablets. Background Art

[0002] Exemestane is an irreversible steroidal aromatase inactivator. It is structurally similar to the enzyme's natural substrate, androstenedione, and is a pseudo-substrate of aromatase. It can inactivate the enzyme by irreversibly binding to its active site, thereby significantly reducing the level of estrogen in the blood circulation of menopausal women, inhibiting estrogen synthesis in postmenopausal women, and thus preventing the growth of breast cancer cells.

[0003] According to literature reports, after oral administration of radiolabeled exemestane by healthy postmenopausal women, it is rapidly absorbed, and at least 42% of exemestane is absorbed in the gastrointestinal tract; after consuming a high-fat meal, the level of exemestane in plasma increases by about 40%. Exemestane is widely distributed in various tissues, and its plasma protein binding rate is 90%. Exemestane has a wide range of metabolism, mainly through oxidation of the 6-methylene group and reduction of the 17-keto group. The metabolites are inactive or have weak inhibition of aromatase activity. Its metabolites are mainly excreted from urine and feces, accounting for about 40% each, and the original drug excreted in urine is less than 1% of the dose. The average terminal half-life of exemestane is 24 hours. The absorption of postmenopausal women with advanced breast cancer is faster than that of healthy postmenopausal women, with peak times of 1.2 hours and 2.9 hours, respectively. After repeated administration, the average oral clearance of patients with advanced breast cancer is 45% lower than that of healthy postmenopausal women, while the level in the circulation is higher; its average AUC is twice that of healthy women.

[0004] Therefore, exemestane has a significant therapeutic effect in the treatment of advanced breast cancer in women after natural or artificial menopause whose disease has progressed after tamoxifen treatment.

[0005] Exemestane is a poorly soluble drug that is almost insoluble in water. It has strong electrostatic adsorption after micronization. During the preparation process, it is difficult to fully disperse the exemestane raw material. It is difficult to solve the problem of mixing uniformity using traditional wet granulation or dry granulation. Therefore, developing an efficient preparation process that fully disperses the raw materials is of great significance to product quality control. Summary of the invention

[0006] The object of the present invention is to provide a fluidized granulation method for exemestane tablets.

[0007] To achieve the above-mentioned purpose and other related purposes, the technical solution provided by the present invention is: a fluidized granulation method for exemestane tablets, preparing raw materials according to the prescription amount of the exemestane tablets, comprising the following steps:

[0008] Step 1: Preparation of adhesive

[0009] Adding hypromellose to purified water, stirring evenly, then adding polysorbate, stirring evenly, to obtain a hypromellose solution;

[0010] Step 2: Raw material suspension

[0011] Add exemestane to the hypromellose solution while stirring until the exemestane is completely dispersed, and sieve to obtain a suspension for later use;

[0012] Step 3: Top spray granulation

[0013] Using a fluidized bed for top spray granulation, mannitol and microcrystalline cellulose are added into the fluidized bed, and the suspension is atomized and sprayed into a boiling hopper;

[0014] Step 4: Whole grains

[0015] The material obtained in step 3 and colloidal silicon dioxide are granulated using a swing granulator.

[0016] The preferred technical solution is: in step 3, the air volume of the fluidized bed is set to 200-500m 3 / h range, inlet air temperature 55-65℃.

[0017] The preferred technical solution is: in step 3, before top spray granulation, the temperature of mannitol and microcrystalline cellulose is preheated to above 35°C.

[0018] The preferred technical solution is: during atomization, the peristaltic pump speed is 60-180 rpm, the feed amount of the suspension is 100-300 ml / min, the atomization pressure is 1.0-3.0 kg; and the temperature of the suspension is controlled to be 28-38°C.

[0019] The preferred technical solution is: after the top spraying of the suspension is completed, the air inlet temperature of the fluidized bed is set to 54-56° C., so that the material in the fluidized bed is dried to a moisture content of less than or equal to 2.0%.

[0020] Due to the application of the above technical solution, the present invention has the following advantages compared with the prior art:

[0021] The present invention fully disperses the raw materials into a solution, and then uses a fluidized top spray granulation process to evenly spray the solution after the raw materials are dispersed on a specific soluble auxiliary material, so that the raw materials are evenly distributed on the surface of the soluble auxiliary material, and a high-quality product with uniform particles, stable dissolution and release, and guaranteed product quality is prepared. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 This is the pH 4.5+0.2SDS dissolution curve.

[0023] Figure 2This is the dissolution curve of the flow cell experiment.

[0024] Figure 3 is the differential data.

[0025] Figure 4 pH 4.5+0.2SDS dissolution curve, basket method 50 rotations. DETAILED DESCRIPTION

[0026] The following is a description of the implementation of the present invention by means of specific embodiments. Those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification.

[0027] See also Figure 1-4 . It should be noted that the structures, proportions, sizes, etc. illustrated in the drawings in this specification are only used to match the contents disclosed in the specification for people familiar with this technology to understand and read, and are not used to limit the limiting conditions for the implementation of the present invention, so they have no substantial technical significance. Any modification of the structure, change in the proportional relationship, or adjustment of the size should still fall within the scope of the technical content disclosed by the present invention without affecting the effects and purposes that can be achieved by the present invention. At the same time, the terms such as "upper", "lower", "left", "right", "middle" and "one" quoted in this specification are only for the convenience of description, and are not used to limit the scope of the implementation of the present invention. Changes or adjustments in their relative relationships should also be regarded as the scope of the implementation of the present invention without substantially changing the technical content.

[0028] Example 1: A fluidized granulation method for exemestane tablets

[0029] The exemestane tablets of the present invention are prepared from the following raw and auxiliary materials in parts by weight:

[0030] Exemestane 25, mannitol 20-30, microcrystalline cellulose 5-15, colloidal silicon dioxide 0.2-0.5, sodium carboxymethyl starch 3-5, magnesium stearate 0.6-1.5, cross-linked polyvinyl alcohol 1-2, hypromellose 2-3, polysorbate 80 0.07-0.13.

[0031] Preferred prescription 1, the weight ratio of its raw materials and auxiliary materials is:

[0032] Exemestane 25, mannitol 30, microcrystalline cellulose 5.8, colloidal silicon dioxide 0.35, sodium carboxymethyl starch 4.2, magnesium stearate 1.05, crospovidone 1.4, hypromellose 2.1, polysorbate 80 0.1.

[0033] Prescription 2:

[0034] Exemestane 25, mannitol 25.5, microcrystalline cellulose 9.63, colloidal silicon dioxide 0.35, sodium carboxymethyl starch 4.2, magnesium stearate 1.05, crospovidone 1.4, hypromellose 2.8, polysorbate 80 0.07.

[0035] Prescription 3:

[0036] Exemestane 25, mannitol 21, microcrystalline cellulose 14.07, colloidal silicon dioxide 0.35, sodium carboxymethyl starch 4.2, magnesium stearate 1.05, crospovidone 1.4, hypromellose 2.8, polysorbate 80 0.13.

[0037] The present invention provides a method for preparing the above-mentioned exemestane tablets, which comprises the following steps:

[0038] Take prescription 2 as an example:

[0039] Material Name Single particle size mg % 300,000 pieces Exemestane 25 35.71 7.5kg Mannitol 25.5 36.43 7.65kg Microcrystalline Cellulose 9.63 13.76 2.889kg Sodium starch glycolate (added) 4.2 6.0 1.26kg Colloidal silicon dioxide (added) 0.35 0.5 0.105kg Cross-linked polyvinylpyrrolidone (added) 1.4 2.0 0.42kg Magnesium Stearate (Added) 1.05 1.5 0.315kg Hydroxypropyl methylcellulose 2.8 4.0 0.84g Polysorbate 80 0.07 0.1 0.021kg Purified water Moderate / 23.16kg Total weight 70 100 21kg

[0040] (a) Preparation of the binder: Weigh 23.16 kg of the prescribed amount of purified water, add 0.84 kg of the prescribed amount of hypromellose, stir until completely dissolved, then add 0.021 kg of the prescribed amount of polysorbate 80, stir evenly, and set aside;

[0041] (b) Raw material suspension: add 7.5 kg of exemestane to the hypromellose solution while stirring until the raw material is completely dispersed, and pass the solution through a 60-mesh sieve for later use;

[0042] (c) Top spray granulation: Use WBF-30 multi-purpose fluidized bed for top spray granulation, add mannitol and microcrystalline cellulose into the fluidized bed, set the air volume in the range of 200-500m3 / h, the air temperature in the range of 55-65℃, and preheat the material temperature to above 35℃. Use a peristaltic pump and turn on the atomization to spray the suspension solution containing the raw materials onto the boiling material in the hopper. During the spraying process, control the air volume in the range of 200-500m3 / h. 3 / h, inlet air temperature 55-65℃, peristaltic pump speed 60-180 rpm (100-300ml / min), atomization pressure 1.0-3.0kg; control the material temperature at 28-38℃.

[0043] (d) Drying: After the top spray granulation of the raw material suspension solution is completed, the air inlet temperature is set to 55°C and dried to a moisture content of less than 2.0%;

[0044] (e) Granulation: The dried material and colloidal silicon dioxide are granulated using an oscillating granulator equipped with a 30-mesh screen.

[0045] (f) Total mixing: Add the granulated material into a mixer, then add sodium carboxymethyl starch, cross-linked polyvinylpyrrolidone and magnesium stearate, set the mixing speed to 10 rpm, and mix for 10 min.

[0046] (g) Tablet pressing: The tablet weight to be pressed is calculated according to "25 mg ÷ Exemestane tablet intermediate product (after total mixing) content". Use S250 rotary tablet press for tablet pressing, the tablet pressing speed is 60,000 tablets / hour to 100,000 tablets / hour, the average hardness is controlled within the range of 4.0-7.0 kg, the friability is ≤0.8﹪, and broken, cracked and crushed tablets shall not be detected; weight difference: the limit is ±7.0﹪.

[0047] (h) Coating: Use a P150 coating machine to coat the tablets. Add the exemestane tablet intermediate product (plain tablet) into the coating machine, set the air inlet temperature at 50°C and the pan speed at 2.0-4.0 rpm, and preheat the tablet core for 10 minutes. After preheating, open the liquid supply valve of the mixing tank, set the air inlet temperature at 45-55°C and the air volume at 1000-2200 m 3 / h range, pan speed range of 2.0-8.0rpm range, atomization pressure range of 1.0-3.0bar range, spray angle pressure range of 1.0-3.0bar range, pump flow rate range of 70-150ml / min range for coating. The coating weight gain is required to be controlled in the range of 1.5%-2.5%.

[0048] The weight ratio of raw materials and auxiliary materials of the exemestane tablets of the present invention has been verified through a large number of strict screening tests, process verification, and stability studies to be reasonable in the ratio of raw materials and auxiliary materials, stable in the preparation process, and stable in the finished preparation, which complies with the requirements of pharmaceutics and the preparation guidelines of the State Food and Drug Administration for tablets.

[0049] After the exemestane tablet preparation of the present invention was completed, a quality comparison study was conducted with the wet granulation granulation process product. Using the same raw materials and excipients, after adjusting the different proportions of excipients, the excipient addition method, the amount of binder added, and other multiple batches of studies, it was found that the dissolution curve of the product prepared by the wet granulation process had a poor fit with the reference preparation, and the dissolution endpoint was low. From the prescription processes of multiple batches of wet granulation studies, a production process that was closest to the reference preparation dissolution curve was selected for comparative analysis:

[0050] Comparative Example: Wet Granulation

[0051] Wet granulation recipe:

[0052]

[0053]

[0054] (a) Preparation of the binder: Weigh 67.9 g of the prescribed amount of purified water, add 2.1 g of the prescribed amount of hypromellose, stir until completely dissolved, then add 0.21 g of polysorbate 80, stir evenly, and set aside;

[0055] (b) Wet granulation: Exemestane, mannitol, sodium starch glycolate, microcrystalline cellulose, and colloidal silicon dioxide were added to a high-efficiency wet granulator, and the stirring speed was set to 300 rpm and the cutting speed was set to 1200 rpm, and the mixture was mixed for 5 minutes. The granulation parameters remained unchanged, and the hypromellose aqueous solution was added. After the addition was completed, the granulation parameters remained unchanged and the mixture was wet mixed for 5 minutes.

[0056] (c) Wet granulation: Use an oscillating granulator equipped with a 30-mesh screen for granulation.

[0057] (d) Drying: Drying is performed using a fluidized bed with the air inlet temperature set at 55°C until the moisture content is less than 2.0%;

[0058] (e) Granulation: The dried material and colloidal silicon dioxide are granulated using an oscillating granulator equipped with a 30-mesh screen.

[0059] (f) Total mixing: Add the granulated material into a mixer, then add cross-linked polyvinylpyrrolidone and magnesium stearate, set the mixing speed to 10 rpm, and mix for 10 min.

[0060] (g) Tablet pressing: Calculate the tablet weight according to "25mg÷exemestane tablet intermediate product (after total mixing) content". Use ZP19 / 2 rotary tablet press for tablet pressing, control the average hardness within the range of 4.0-7.0kg, friability ≤0.8﹪, and do not detect broken, cracked or crushed tablets; weight difference: limit is ±7.0﹪.

[0061] (h) Coating: Use BGB-5FA coating machine for coating, add the intermediate product of exemestane tablets (plain tablets) into the coating machine, set the air inlet temperature at 50°C, the pan speed at 2.0-4.0rpm, and preheat the tablet core for 10 minutes. After preheating, set the air inlet temperature at 45-55°C, the air inlet volume at 1000-2200m3 / h, the pan speed at 2.0-8.0rpm, the atomization pressure at 0.06-1.0Mpa, and the pump flow at 4-8ml / min for coating. The coating weight gain is required to be controlled within the range of 1.5﹪-2.5﹪.

[0062] The dissolution curves of the products produced by fluidized bed granulation and wet granulation were compared, and the results are as follows:

[0063]

[0064] from Figure 1It can be seen that the dissolution curve of the product granulated by fluidized bed is basically consistent with the reference preparation, with a good fit, while the dissolution curve of the product granulated by wet method is inconsistent with the reference preparation, with a poor fit. Moreover, the RSD value of the product granulated by fluidized bed is very small, indicating that the product quality uniformity is good.

[0065] In order to further understand the dissolution and release rate of the product, the flow cell dissolution data of the products of the two processes were compared. The results are as follows:

[0066]

[0067]

[0068] It can be seen from the test results of the circulation pool that both the cumulative value and the differential value can reflect that the results of fluidized one-step granulation are basically consistent with the reference, and are better than the wet granulation results.

[0069] In order to further determine that the product quality of the present invention is stable and reliable, the pilot batch production and three batches of process verification were carried out on the present invention, and quality research was conducted, and the inspection methods of various indicators were formulated. According to the guiding principles of the Chinese Pharmacopoeia and new drug research, the methodological verification of the detection methods of various indicators was carried out. All methods meet the requirements of preparation analysis. According to these methods, the developed exemestane tablets were tested and studied, proving that the preparation process of the present invention can continuously and stably produce high-quality products that are consistent with the reference preparation. The following is a statistical analysis of some research data of the pilot and three batches of process verification as follows:

[0070] 1. According to the raw material formula and preparation method of the implementation prescription 2, the total mixed granules prepared in the pilot and verification batches, the test results of various indicators are shown in Table 1:

[0071] Table 1: Powder evaluation of the total mixed particles

[0072] Product Name Bulk density g / ml Tap density g / ml Angle of repose Carr Index Pilot batch 0.395 0.485 36.5o 19% Verification batch 1 0.383 0.481 35.3o 20% Verification batch 2 0.421 0.521 35o 19% Verification batch 3 0.398 0.491 36o 19%

[0073] It can be seen from the Carr index of the particles that the particles prepared using the fluidized bed have good fluidity and are basically stable.

[0074] 2. According to the raw material formula and preparation method of Prescription 2, the test results of various indicators of the plain tablets prepared in the pilot and verification batches are shown in Table 2:

[0075] Table 2: Test results of plain tablets

[0076] Product Name hardness friability Pilot batch 5.5kg 0.1% Verification batch 1 4.6kg 0.1% Verification batch 2 4.5kg 0.2% Verification batch 3 5.2kg 0.2%

[0077] From the statistical results, it can be seen that the hardness of the plain tablets meets the requirements and the brittleness is relatively small.

[0078] 3. According to the raw material formula and preparation method of Prescription 2, the test results of various indicators of the coated tablets prepared in the pilot and verification batches are shown in Table 3:

[0079] Table 3: Test results of coated tablets

[0080] Product Name Coating weight gain Appearance Pilot batch 2.4% qualified Verification batch 1 2.3% qualified Verification batch 2 2.1% qualified Verification batch 3 1.9% qualified

[0081] 4. The dissolution curves of the finished products prepared in pilot and validation batches according to the raw material formula and preparation method of prescription 2 are compared with those of the reference preparations as shown in Table 4. Figure 1 :

[0082] Table 4 Comparison of dissolution curves of exemestane tablets made in-house and reference

[0083]

[0084]

[0085] From the dissolution results of the pilot batch and three batches of process verification, it can be seen that the dissolution curve of the product is basically consistent with that of the reference preparation, indicating that the production process of the product is relatively stable and can produce continuously stable products.

[0086] 5. The stability data of the finished products prepared in the pilot and validation batches according to the raw material formula and preparation method of the implementation prescription 2 are compared with the reference preparation for 6 months. See the following table:

[0087]

[0088] It can be seen from the product stability data that the product has good stability after 6 months of accelerated experiments. Since the homemade preparation is a film-coated tablet and the reference preparation is a sugar-coated tablet, although the homemade preparation of related substances is slightly higher than the reference preparation, it is far below the standard limit. Therefore, the preparation process of the present invention has high production efficiency, and the quality of the products produced is reliable and stable.

[0089] Example 2: A fluidized granulation method for exemestane tablets

[0090] A fluidized granulation method for exemestane tablets, comprising preparing raw materials according to the prescription amount of the exemestane tablets, comprising the following steps:

[0091] Step 1: Preparation of adhesive

[0092] Adding hypromellose to purified water, stirring evenly, then adding polysorbate, stirring evenly, to obtain a hypromellose solution;

[0093] Step 2: Raw material suspension

[0094] Add exemestane to the hypromellose solution while stirring until the exemestane is completely dispersed, and sieve to obtain a suspension for later use;

[0095] Step 3: Top spray granulation

[0096] Using a fluidized bed for top spray granulation, mannitol and microcrystalline cellulose are added into the fluidized bed, and the suspension is atomized and sprayed into a boiling hopper;

[0097] Step 4: Whole grains

[0098] The material obtained in step 3 and colloidal silicon dioxide are granulated using a swing granulator.

[0099] The preferred embodiment is: in step 3, the air volume of the fluidized bed is 200m 3 / h range, inlet air temperature 55℃.

[0100] A preferred embodiment is as follows: in step 3, before top spray granulation, the temperature of mannitol and microcrystalline cellulose is preheated to above 35°C.

[0101] The preferred embodiment is: during atomization, the peristaltic pump speed is 60 rpm, the feed amount of the suspension is 100 ml / min, the atomization pressure is 1.0 kg; and the temperature of the suspension is controlled to be 28°C.

[0102] A preferred implementation is: after the suspension is top-sprayed, the air inlet temperature of the fluidized bed is set to 54° C., so that the material in the fluidized bed is dried to a moisture content of less than or equal to 2.0%.

[0103] Example 3: A fluidized granulation method for exemestane tablets

[0104] A fluidized granulation method for exemestane tablets, comprising preparing raw materials according to the prescription amount of the exemestane tablets, comprising the following steps:

[0105] Step 1: Preparation of adhesive

[0106] Adding hypromellose to purified water, stirring evenly, then adding polysorbate, stirring evenly, to obtain a hypromellose solution;

[0107] Step 2: Raw material suspension

[0108] Add exemestane to the hypromellose solution while stirring until the exemestane is completely dispersed, and sieve to obtain a suspension for later use;

[0109] Step 3: Top spray granulation

[0110] Using a fluidized bed for top spray granulation, mannitol and microcrystalline cellulose are added into the fluidized bed, and the suspension is atomized and sprayed into a boiling hopper;

[0111] Step 4: Whole grains

[0112] The material obtained in step 3 and colloidal silicon dioxide are granulated using a swing granulator.

[0113] The preferred embodiment is: in step 3, the air volume of the fluidized bed is 500m 3 / h range, inlet air temperature 65℃.

[0114] A preferred embodiment is as follows: in step 3, before top spray granulation, the temperature of mannitol and microcrystalline cellulose is preheated to above 35°C.

[0115] The preferred embodiment is: during atomization, the peristaltic pump speed is 180 rpm, the feed amount of the suspension is 300 ml / min, the atomization pressure is 3.0 kg; and the temperature of the suspension is controlled to be 38°C.

[0116] A preferred implementation is: after the suspension is top-sprayed, the air inlet temperature of the fluidized bed is set to 56° C., so that the material in the fluidized bed is dried to a moisture content of less than or equal to 2.0%.

[0117] The above description is only used to explain the preferred embodiments of the present invention, and is not intended to limit the present invention in any form. Therefore, any modifications or changes made to the present invention under the same inventive spirit should still be included in the scope of protection intended by the present invention.

Claims

1. A fluidized granulation method for exemestane tablets, Features: The raw materials are prepared according to the prescription amount of the exemestane tablets, including the following steps: Step 1: Preparation of adhesive Adding hypromellose to purified water, stirring evenly, then adding polysorbate, stirring evenly, to obtain a hypromellose solution; Step 2: Raw material suspension Add exemestane to the hypromellose solution while stirring until the exemestane is completely dispersed, and sieve to obtain a suspension for later use; Step 3: Top spray granulation Using a fluidized bed for top spray granulation, mannitol and microcrystalline cellulose are added into the fluidized bed, and the suspension is atomized and sprayed into a boiling hopper; Step 4: Whole grains The material obtained in step 3 and colloidal silicon dioxide are granulated using a swing granulator.

2. The fluidized granulation method for exemestane tablets according to claim 1, Features: In step 3, the air volume of the fluidized bed is set to 200-500m 3 / h range, inlet air temperature 55-65℃.

3. The fluidized granulation method for exemestane tablets according to claim 1, Features: In step 3, before top spray granulation, the temperature of mannitol and microcrystalline cellulose is preheated to above 35°C.

4. The fluidized granulation method for exemestane tablets according to claim 1, Features: During atomization, the peristaltic pump speed is 60-180 rpm, the feed amount of the suspension is 100-300 ml / min, the atomization pressure is 1.0-3.0 kg; the temperature of the suspension is controlled to be 28-38°C.

5. The fluidized granulation method for exemestane tablets according to claim 1, Features: After the top spraying of the suspension is completed, the air inlet temperature of the fluidized bed is set to 54-56° C. to dry the materials in the fluidized bed to a moisture content of less than or equal to 2.0%.